Schaper Benz & Wise Investment Counsel Inc Abbott Laboratories Transaction History
Schaper Benz & Wise Investment Counsel Inc
- $1.21 Billion
- Q4 2024
A detailed history of Schaper Benz & Wise Investment Counsel Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Schaper Benz & Wise Investment Counsel Inc holds 166,304 shares of ABT stock, worth $22.4 Million. This represents 1.55% of its overall portfolio holdings.
Number of Shares
166,304
Previous 168,150
1.1%
Holding current value
$22.4 Million
Previous $19.2 Million
1.88%
% of portfolio
1.55%
Previous 1.58%
Shares
31 transactions
Others Institutions Holding ABT
# of Institutions
3,361Shares Held
1.36BCall Options Held
10.6MPut Options Held
8.73M-
Vanguard Group Inc Valley Forge, PA169MShares$22.8 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10.4 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$9.17 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.3 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $236B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...